- Home
- NEGG vs TNYA Comparison
NEGG vs TNYA Comparison
Compare NEGG & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEGG
- TNYA
- Stock Information
- Founded
- NEGG 2001
- TNYA 2016
- Country
- NEGG United States
- TNYA United States
- Employees
- NEGG N/A
- TNYA N/A
- Industry
- NEGG Other Specialty Stores
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- NEGG Consumer Discretionary
- TNYA Health Care
- Exchange
- NEGG Nasdaq
- TNYA Nasdaq
- Market Cap
- NEGG 122.3M
- TNYA 111.1M
- IPO Year
- NEGG 2010
- TNYA 2021
- Fundamental
- Price
- NEGG $64.68
- TNYA $0.66
- Analyst Decision
- NEGG
- TNYA Strong Buy
- Analyst Count
- NEGG 0
- TNYA 5
- Target Price
- NEGG N/A
- TNYA $8.60
- AVG Volume (30 Days)
- NEGG 1.3M
- TNYA 2.4M
- Earning Date
- NEGG 08-28-2025
- TNYA 08-15-2025
- Dividend Yield
- NEGG N/A
- TNYA N/A
- EPS Growth
- NEGG N/A
- TNYA N/A
- EPS
- NEGG N/A
- TNYA N/A
- Revenue
- NEGG $1,235,576,000.00
- TNYA N/A
- Revenue This Year
- NEGG N/A
- TNYA N/A
- Revenue Next Year
- NEGG N/A
- TNYA N/A
- P/E Ratio
- NEGG N/A
- TNYA N/A
- Revenue Growth
- NEGG N/A
- TNYA N/A
- 52 Week Low
- NEGG $3.32
- TNYA $0.36
- 52 Week High
- NEGG $69.50
- TNYA $4.01
- Technical
- Relative Strength Index (RSI)
- NEGG 67.17
- TNYA 43.13
- Support Level
- NEGG $25.49
- TNYA $0.64
- Resistance Level
- NEGG $69.50
- TNYA $0.80
- Average True Range (ATR)
- NEGG 9.01
- TNYA 0.08
- MACD
- NEGG 2.65
- TNYA -0.03
- Stochastic Oscillator
- NEGG 89.05
- TNYA 4.48
About NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally. Geographically, it operates in United States, Canada, and Rest of World.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.